fda declaratory order semaglutide shortage resolved Hims: Why The May End Imminently FDA Issues Order on Resolution
Description
Retatrutide is still investigational and not widely approved for clinical use, whereas Tirzepatide is already approved and more widely accessible

Key Findings Zepbound users noted hypertension concerns: Hypertension appeared more frequently in discussions of this newer tirzepatide brand (0.73% of posts)
That matters because weight loss does not necessarily equate to better health, especially if too much of that loss comes from the muscle

But the landscape is evolving rapidly

Retatrutide demonstrates definitive visceral fat loss clinical evidence

Robert Kushner Mike Haney: Do you see a world in which a much bigger portion of the population is taking these drugs
